Section Arrow
BFRI.NASDAQ
- Biofrontera
Quotes are at least 15-min delayed:2026/05/13 08:30 EDT
Pre Market
Last
 1
-0.01 (-0.99%)
Bid
0.9701
Ask
1
High 1.021 
Low
Volume 12.40K 
Regular Hours (Closed)
Last
 1.01
-0.1 (-9.01%)
Day High 
1.12 
Prev. Close
1.11 
1-M High
1.19 
Volume 
464.06K 
Bid
0.9701
Ask
1
Day Low
0.98 
Open
1.12 
1-M Low
Market Cap 
13.33M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.12 
20-SMA 1.1 
50-SMA 0.97 
52-W High 1.19 
52-W Low 0.536 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.04/0.14
Enterprise Value
19.16M
Balance Sheet
Book Value Per Share
0.87
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
41.71M
Operating Revenue Per Share
2.42
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health25.03-4.11-14.10%57.14PE
Pre Market 24.61 -0.42 -1.68%
ZTSZOETIS76.94+0.27+0.35%12.61PE
Pre Market 76.9 -0.04 -0.05%
CPHIChina Pharma Holdings Inc0.8927+0.35855+67.13%-- 
Pre Market 0.8354 -0.0573 -6.42%
VTRSViatris17.17+0.25+1.48%-- 
Pre Market 17.11 -0.06 -0.35%
ELANElanco Animal Health21.43-0.29-1.34%-- 
Pre Market 21.6 +0.17 +0.79%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products,which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.